Spirituality/Medicine Interface Project

Face Transplants: Is the Genie Out of the Bottle?

Authors: Iain Hutchison, FSRF


This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Facial Transplantation Working Party Report. The Royal College of Surgeons of England. London UK, 2003.
2. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002;2:807–818.
3. Gao SZ, Chaparro SV, Perlroth M, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant2003;22:505–514.
4. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. New Engl J Med2003;348:1681–1691.
5. Kennedy I, Grubb A. Medical Law: texts with materials. London, Butterworths, 1994, pp 1042–1067.